Rod Raynovich's  Instablog

Rod Raynovich
Send Message
Rod Raynovich is an entrepreneur and executive with a focus on life science companies and medical technology trends.He has over 30 years executive experience including Abbott and JNJ and has been involved three successful start-ups. He has a B.S, from Penn State University and an MBA from... More
My company:
Raygent Capital
My blog:
raygent.com
  • Biotech Sell-Off Resumes: Caution Update 4/4 0 comments
    Apr 4, 2014 12:16 PM | about stocks: XBI

    Update 4/4/14 Breach of Technicals-A Tad Below Early February Support

    Glut of Biotech IPOs Causing Indigestion?

    Momentum Days Are So Over

    NASDAQ Down 1.34%

    The volatile and speculative SPDR S&P Biotech XBI hit $136 in early trading down 2.28%. After a brief rally early this week to the $148 level volume picked up with sellers. The IBB ($230.94) focused more in larger cap biopharmas is also down over 2% and is now only up 1% YTD after hitting a FEB 25 high of $273. Another red screen day with many widely held stocks down 3%. Abbvie (NYSE:ABBV) and Bristol Myers (NYSE:BMY) are holding the green.

    Red Screen after Three Day Rally-February Lows Still Holding

    Many widely held biopharmaceutical stocks are down today as NASDAQ turns negative down 0.38% or 16 points. Here are selected quotes as of 11 am EDT:

    Aegerion (AEGR $42.56) down 4%

    Alexion (ALXN $150) down 2.9%

    Celgene (CELG $143.70) down 2.5%

    Gilead (GILD $72.60) down 1.87%

    IBB ($235) down 2.73%

    Illumina (ILMN $151) down 3.53%

    Incyte (INCY $52) down 4.3%

    Seattle Genetics (SGEN $42) down 4%

    Vertex (NASDAQ:VRTX) down 3.83%

    XBI ($139.26) down 3.57%

    (click to enlarge)

    Disclosure: I am long GILD, ABBV.

    Additional disclosure: Long FBIOX Fidelity Biotech and short XBI as a hedge.

    Stocks: XBI
Back To Rod Raynovich's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.